Self-illuminating activatable chemotherapy enabled by pH-MPO-ROS cascade-amplified nanoparticles for cancer and metastatic lymph nodes
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Cancer Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions10.1038/s41392-023-01576-4 ↗
2. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials10.1200/JCO.2009.25.3617 ↗
3. Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement10.1097/PAS.0b013e3182886ced ↗
4. Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma10.1002/1097-0142(19950315)75:6<1327::AID-CNCR2820750615>3.0.CO;2-P ↗
5. Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging10.1200/JCO.2012.47.3520 ↗
6. Dynamic CD8(+) T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes10.1016/j.cell.2023.02.021 ↗
7. The primordial differentiation of tumor-specific memory CD8(+) T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes10.1016/j.cell.2022.09.020 ↗
8. Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers?10.1038/ncponc0293 ↗
9. Efficacy and clinical significance of omitting blue dye injection during sentinel lymph node biopsy before Mohs micrographic surgery for malignant melanoma of the lower extremities10.1111/bjd.18121 ↗
10. Therapeutic applications of nanobiotechnology10.1186/s12951-023-01909-z ↗
11. Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions10.1186/s12951-023-01977-1 ↗
12. A pH-responsive and guanidinium-rich nanoadjuvant Efficiently delivers STING agonist for cancer immunotherapy10.1021/acsnano.4c10202 ↗
13. Biomimetic cascade nanozyme catalytic system for the treatment of lymph node metastasis in gastric cancer
14. A tumor-activatable liposomal nanoprobe for selective visualization of metastatic lymph nodes10.1002/adhm.202401935 ↗
15. A multi-functional nanoadjuvant coupling manganese with toll-like 9 agonist stimulates potent innate and adaptive anti-tumor immunity
16. Dawn of lipid nanoparticles in lymph node targeting: Potential in cancer immunotherapy10.1016/j.addr.2020.06.003 ↗
17. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing10.1056/NEJMoa1113205 ↗
18. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel10.1158/1078-0432.CCR-05-1634 ↗
19. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma10.1200/JCO.1995.13.4.914 ↗
20. Doxil®--the first FDA-approved nano-drug: lessons learned10.1016/j.jconrel.2012.03.020 ↗
21. Current multistage drug delivery systems based on the tumor microenvironment10.7150/thno.16684 ↗
22. Stimuli-responsive prodrug-based cancer nanomedicine10.1016/j.ebiom.2020.102821 ↗
23. A pH-responsive nanoparticle library with precise pH tunability by co-polymerization with non-ionizable monomers10.1002/anie.202200152 ↗
24. A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals10.1038/nmat3819 ↗
25. A pyroptosis nanotuner for cancer therapy10.1038/s41565-022-01125-0 ↗
26. Lysosome-mitochondria cascade targeting nanoparticle drives robust pyroptosis for cancer immunotherapy10.1021/jacs.4c12264 ↗
27. pH-Amplified cret nanoparticles for in vivo imaging of tumor metastatic lymph nodes10.1002/anie.202102044 ↗
28. Myeloperoxidase - a bridge linking inflammation and oxidative stress with cardiovascular disease10.1016/j.cca.2019.02.022 ↗
29. Cooperativity principles in self-assembled nanomedicine10.1021/acs.chemrev.8b00195 ↗
30. Organosilica-based hollow mesoporous bilirubin nanoparticles for antioxidation-activated self-protection and tumor-specific deoxygenation-driven synergistic therapy10.1021/acsnano.9b02477 ↗
31. situ generation of hybrid alginate hydrogels for enhanced breast tumor ferrotherapy through multiplex magnifying redox imbalances
32. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism10.1016/j.cell.2011.02.022 ↗
33. Rifampin induces expression of p-glycoprotein on the THP1 cell-derived macrophages, causing decrease intramacrophage concentration of prothionamide10.1016/j.xphs.2019.04.009 ↗
34. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis10.1016/j.cell.2006.01.007 ↗
35. Specific diagnosis of lymph node micrometastasis in breast cancer by targeting activatable near-infrared fluorescence imaging10.1016/j.biomaterials.2022.121388 ↗
36. Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice10.1126/science.aal3622 ↗